Impact Factor Journals

CHROMÁ, K., Z. ŠKROTT, J. GURSKÝ, J. BACOVSKY, P. MOUDRÝ, T. BUCHTOVÁ, M. MISTRÍK, J. BÁRTEK
A drug repurposing strategy for overcoming human multiple myeloma resistance to standard-of-care treatment. Cell Death & Disease. 2022, 13(3), 203, ISSN: 2041-4889, PMID: 35246527,
LUŽNÁ, P., D. WEISER DROZDKOVA, P. FLODROVÁ, K. ONDRUSKOVA, I. ÜBERALL, J. MINARIK, Z. KOLÁŘ, K. SMEŠNÝ TRTKOVÁ
Global DNA methylation and increased DNMT3A expression in multiple myeloma patients. Biomedical Papers - Olomouc. 2022, ISSN: 1213-8118, PMID: 35173353,
MACEČKOVÁ, Z., A. KUBÍČKOVÁ, J. DE SANCTIS, M. HAJDÚCH
Effect of Glucocorticosteroids in Diamond-Blackfan Anaemia: Maybe Not as Elusive as It Seems. International Journal of Molecular Sciences. 2022, 8(23), 3, ISSN: 1422-0067, PMID: 35163808,  PDF.
HAVRDOVA, M., I. URBANCIC, K. BARTOŇ TOMÁNKOVÁ, L. MALINA, K. POLAKOVA, J. STRANCAR, A. BOURLINOS
Intracellular Trafficking of Cationic Carbon Dots in Cancer Cell Lines MCF-7 and HeLa-Time Lapse Microscopy, Concentration-Dependent Uptake, Viability, DNA Damage, and Cell Cycle Profile. International Journal of Molecular Sciences. 2022, 23(3), 1077, ISSN: 1422-0067, PMID: 35162996,  PDF.
ŠTUDENTOVÁ, H., J. VOLAKOVA, M. SPISAROVÁ, A. ZEMÁNKOVÁ, K. AIGLOVA, T. SZOTKOWSKI, B. MELICHAR
Severe tyrosine-kinase inhibitor induced liver injury in metastatic renal cell carcinoma patients: two case reports assessed for causality using the updated RUCAM and review of the literature. BMC Gastroenterology. 2022, 22(1), 49, ISSN: 1471-230X, PMID: 35123392,
ZACHOVÁ, K., J. JEMELKOVA, P. KOSZTYU, Y. OHYAMA, K. TAKAHASHI, J. ZADRAZIL, J. ORSAG, K. MATOUSOVIC, D. GALUSZKOVÁ, N. PETEJOVA, J. MESTECKY, M. RAŠKA
Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors. Journal of the American Society of Nephrology. 2022, 33(5), 908-917, ISSN: 1046-6673, PMID: 35115327,
SPURNA, Z., Z. CAPKOVA, J. SROVNAL, J. DUCHOSLAVOVÁ, L. PUNOVA, D. ALEKSIJEVIC, R. VRTEL
Clinical impact of variants in non-coding regions of SHOX - current knowledge. Gene. 2022, 818, 146238, ISSN: 0378-1119, PMID: 35074420,  PDF.
KOTULOVÁ, J., K. LÓNOVÁ, A. KUBÍČKOVÁ, J. VRBKOVÁ, P. KOUŘILOVÁ, M. HAJDÚCH, P. DŽUBÁK
2‑Cl‑IB‑MECA regulates the proliferative and drug resistance pathways, and facilitates chemosensitivity in pancreatic and liver cancer cell lines. International Journal of Molecular Medicine. 2022, 49(3), 31, ISSN: 1107-3756, PMID: 35039871,
WOLRAB, D., R. JIRASKO, E. CIFKOVA, M. HORING, D. MEI, M. CHOCHOLOUSKOVA, O. PETERKA, J. IDOWIAK, T. HRNCIAROVA, L. KUCHAR, R. AHRENDS, R. BRUMAROVÁ, D. FRIEDECKÝ, G. VIVO-TRUYOLS, P. SKRHA, J. SKRHA, R. KUCERA, B. MELICHAR, G. LIEBISCH, R. BURKHARDT, M. WENK, A. CAZENAVE-GASSIOT, P. KARASEK, I. NOVOTNY, K. GREPLOVA, R. HRSTKA, M. HOLCAPEK
Lipidomic profiling of human serum enables detection of pancreatic cancer. Nature Communications. 2022, 13(1), 124, ISSN: 2041-1723, PMID: 35013261,
ORTEGA, A., I. VERA, M. DÍAZ, C. NAVARRO, M. ROJAS, W. TORRES, H. PARRA, J. SALAZAR, J. DE SANCTIS, V. BERMUDEZ
The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises. Molecular Sciences. 2021, 23(1), 430, ISSN: 1422-0067, PMID: 35008857,  PDF.